"Drug Utilization Review" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.
|Drug Utilization Review
- Drug Utilization Review
- Evaluation, Drug Utilization
- Drug-Use Review
- Drug Use Review
- Drug-Use Reviews
- Reviews, Drug-Use
- Review, Drug Utilization
- Drug Utilization Reviews
- Reviews, Drug Utilization
- Utilization Reviews, Drug
- Utilization Review, Drug
- Drug Utilization Evaluation
- Drug Utilization Evaluations
- Evaluations, Drug Utilization
- Utilization Evaluation, Drug
- Utilization Evaluations, Drug
- Review, Drug-Use
- Review, Drug Use
Below are MeSH descriptors whose meaning is more general than "Drug Utilization Review".
Below are MeSH descriptors whose meaning is more specific than "Drug Utilization Review".
This graph shows the total number of publications written about "Drug Utilization Review" by people in this website by year, and whether "Drug Utilization Review" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Drug Utilization Review" by people in Profiles.
Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs. J Manag Care Spec Pharm. 2015 Dec; 21(12):1214-34.
Effect of a community-wide asthma intervention on appropriate use of inhaled corticosteroids. J Urban Health. 2011 Feb; 88 Suppl 1:144-55.
U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey. Pharmacoepidemiol Drug Saf. 2009 Nov; 18(11):1094-100.
Prioritizing future research on off-label prescribing: results of a quantitative evaluation. Pharmacotherapy. 2008 Dec; 28(12):1443-52.
The impact of the Medicare Part D prescription benefit on generic drug use. J Gen Intern Med. 2008 Oct; 23(10):1673-8.
Health care provider knowledge of drug formulary status in ambulatory care settings. Am J Health Syst Pharm. 2004 Dec 15; 61(24):2657-63.
Computerized reminders reduce the use of medications during shortages. J Am Med Inform Assoc. 2004 Jul-Aug; 11(4):278-80.
Can a pain management and palliative care curriculum improve the opioid prescribing practices of medical residents? J Gen Intern Med. 2002 Aug; 17(8):625-31.
Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med. 1999 Dec; 6(12):1232-42.
Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics. J Gen Intern Med. 1997 Sep; 12(9):563-6.